Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article

Erratum for "Wortmannin as targeted therapeutic agent for the treatment of triple-negative breast cancer"

1Jian Li , 1Fei Liu, 2Yang Liu.

1Department of Breast Surgery; 2Department of General Surgery, Taian City Central Hospital, Taian 271000, China.

For correspondence:-  Jian Li   Email: my-li@163.com   Tel:+865386298057

Received: 22 May 2015        Accepted: 10 December 2015        Published: 29 January 2016

Citation: Li J, Liu F, Liu Y. Erratum for "Wortmannin as targeted therapeutic agent for the treatment of triple-negative breast cancer". Trop J Pharm Res 2017; 16(1):1-1 doi: http://dx.doi.org/10.4314/tjpr.v16i1.1

2017 Pharmacotherapy Group.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

This article is not free

To view this item, select one of the options below:

Subscribe or Login as Subscriber

Sign in if you are already a Subscribe

Register as a Subscriber

Purchase Short-term Access

Pay per Article - You may Add to Cart and purchase it for US$.00

            


Email updates

Keep up to date with the latest  content from this journal.